STOCKHOLDERS' DEFICIENCY (Tables)

12 Months Ended

Dec. 31, 2016

Stockholders' Equity Note [Abstract]

Schedule of share-based compensation, stock options, activity

A summary of the Company's options activity and related information with respect to options granted to employees and directors during the years ended December 31, 2016 are as follows:

					Weighted
			Weighted		average
			average		remaining		Aggregate
	Number of		exercise		contractual		intrinsic
	options		price		life		value
Outstanding - beginning of the year		805,743	$	2.80		8.40		2,564
Granted		410,038	$	5.69
Exercised		(12,382)	$	2.66
Expired or Forfeited		(1,393)	$	38.36
Outstanding - end of the year		1,202,006	$	3.75		8.18		3,419
Vested and expected to vest		1,202,006	$	3.75		8.18		3,419
Exercisable at end of year		510,968	$	2.80		6.89		2,347

Schedule of share-based compensation arrangements by share-based payment award

The Company's outstanding options granted to consultants as of December 31, 2016 are as follows:

			Weighted
	Options for		Average
	Common		exercise price		Options
Issuance date	stock		per share		exercisable		Expiration date
April 2007		357	$	24.21		357	April 2017
December 2007		1,500	$	84.56		1,500	December 2017
April 2009		1,071	$	72.45		1,071	April 2019
December 2010		786	$	1.99		786	December 2020
March 2013		30,000	$	1.96		30,000	March 2023
October 2013		1,000	$	1.96		1,000	October 2023
February 2015		714	$	1.96		714	February 2025
Total		35,428	$	7.81		35,428

Schedule of employee service share-based compensation, allocation of recognized period costs

The stock based expense recognized in the financial statements for services received from employees is shown in the following table:

	Year ended
	December 31,
	2016		2015
Research and development	$	30	$	22
Selling and marketing		12		9
General and administrative		417		189
Total	$	459	$	220